share_log

Atara Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(4.6%),Citadel Advisors Holdings LP(4.6%), etc.

Atara Biotherapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Citadel Advisors LLC(4.6%),Citadel Advisors Holdings LP(4.6%)等

美股SEC公告 ·  2024/11/14 15:31
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息